Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

Click for more information

0.00%

20.5¢ raptor resources limited

Ann: ResApp Enrols First Patient in SMARTCOUGH-C-2 Study, page-15

First 15 Last

Share
Profile

Follow
AlCp

26,999 Posts.

1742

08/01/18

15:11

Post #: 30130361
Share

Originally posted by TerribleTadpole ↑

"we now have a world class institute managing" — we had this in the first try as well. The error wasn't in choosing a bad CRO, it was in choosing a CRO with the wrong background and not realising that the difference is important.

"updated algorithms" — they're not updated. The application has a better user interface, and some added validation features to ensure that the collected data is of usable quality. But the algorithm is the same.

On a broader note, I don't expect the current pip to hold. This announcement doesn't really alter the risk profile. There was never any significant risk that the trials wouldn't begin. I believe that significant reduction in risk will be perceived from:

1) release of some good double-blind results, and
2) the first Smartcough-C-2 update if they can release good data quality monitoring results.

I would expect significant and sustained re-rates from each of these events.

Expand

You haven't been doing DT again have you????.......but the 10c is a big barrier.

RAP Price at posting: 9.0¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

Your questions From the Floor: Fenix Resources (ASX:FEX)

From the Floor with Kim Beazley at Diggers and Dealers 2024

From the Floor: Minerals Council WA chief talks uranium and gold

AAR

Your questions From the Floor: Astral Resources (ASX:AAR)

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

There are more pages in this discussion • 13 more messages in this thread...

First 15 Last

Add RAP (ASX) to my watchlist